medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2025, Number 2

<< Back Next >>

Rev Mex Urol 2025; 85 (2)

Metastatic Wilms’ tumor in young adult: case report

Vázquez AJ, Olivares PS, Meneses MI, Arciniega VE, Díaz JE, Morrrugares IM, Ocampo BA

Language: Spanish
References: 23
Page: 1-9
PDF size: 232.24 Kb.


ABSTRACT

Clinical case: a 20-year-old male patient with type 1 obesity presents with abdominal and dorsal pain. Pathological diagnosis reported Wilms tumor (WT) stage IV. He received preoperative chemotherapy and subsequently underwent left radical nephrectomy. Currently, the patient remains asymptomatic and without evidence of recurrence 12 months after surgery.
Relevance: Wilms tumor or nephroblastoma is an uncommon pathology in the adult population with very few reported cases. The advanced stage of the disease complicates surgical and oncologic treatment.
Medical implications: currently, there are no defined guidelines for the treatment of WT in the adult population due to its low frequency and the lack of information on the strategies employed in high-specialty hospitals where these cases have been managed.
Conclusions: the therapeutic approach of WT in adults presents significant challenges, making it necessary to establish a standardized model of care and management. The partial response to chemotherapy and the appearance of new lesions indicates the possibility of requiring additional treatments, as well as strict surveillance. Systematic recording and analysis of these cases will contribute to the development of more effective therapeutic strategies for this rare clinical entity.


REFERENCES

  1. Mitry E, Ciccolallo L, Coleman MP, GattaG, Pritchard-Jones K, EUROCARE WorkingGroup. Incidence of and survival fromWilms’ tumour in adults in Europe: data fromthe EUROCARE study. European Journal ofCancer (Oxford, England: 1990). 2006;42(14): 2363–2368. https://doi.org/10.1016/j.ejca.2006.04.009.

  2. Tripathi S, Mishra A, Popat VC, Husain SA.Wilms’ Tumor in Adults—Conventional andUnconventional Presentations of a Rare Entitywith a Review of Literature. Journal of KidneyCancer and VHL. 2021;8(2): 40–48. https://doi.org/10.15586/jkcvhl.v8i2.186.

  3. Zhao Q, Xiong Q, Song Q. Metastatic adultWilms’ tumor managed by chemotherapy,immunotherapy and target therapy: a casereport. Future Science OA. 10(1): FSO915.https://doi.org/10.2144/fsoa-2023-0156.

  4. Mounnarath ET, Zwieky W, Aedo-Lopez V,Fazli O, Sheridan BJ. Adult Wilms tumour: Acase report. SAGE Open Medical Case Reports.2022;10: 2050313X221097265. https://doi.org/10.1177/2050313X221097265.

  5. Huszno J, Starzyczny–Słota D, Jaworska M,Nowara E. Adult Wilms’ tumor – diagnosisand current therapy. Central European Journalof Urology. 2013;66(1): 39–44. https://doi.org/10.5173/ceju.2013.01.art12.

  6. Pérez-García J, Machado I, Calabuig-FariñasS, Navarro S, Llombart-Bosch A, Pérez-GarcíaJ, et al. Tumor de Wilms con diferenciaciónmuscular. Histología, inmunofenotipo y análisismolecular de tres casos. Revista Espanola dePatologia. 2012;45(2): 67–75. https://doi.org/10.1016/J.PATOL.2011.11.007.

  7. Apple A, Lovvorn HN. Wilms Tumor inSub-Saharan Africa: Molecular and SocialDeterminants of a Global Pediatric HealthDisparity. Frontiers in Oncology. 2020;10: 606380.https://doi.org/10.3389/fonc.2020.606380.

  8. Reinhard H, Aliani S, Ruebe C, Stöckle M,Leuschner I, Graf N. Wilms’ Tumor in Adults:Results of the Society of Pediatric Oncology(SIOP) 93-01/Society for Pediatric Oncologyand Hematology (GPOH) Study. Journal ofClinical Oncology. 2004;22(22): 4500–4506.https://doi.org/10.1200/JCO.2004.12.099.

  9. Steliarova-Foucher E, Colombet M, Ries LAG,Moreno F, Dolya A, Bray F, et al. Internationalincidence of childhood cancer, 2001-10: apopulation-based registry study. The Lancet.Oncology. 2017;18(6): 719–731. https://doi.org/10.1016/S1470-2045(17)30186-9.

  10. Zhang JJ, Yang LF, Zhang YZ, Xie XH. Clinicalvalue of ultrasound in adult Wilms’ tumor patientwith uremia: A case report and literature review.Medicine. 2023;102(49): e36381. https://doi.org/10.1097/MD.0000000000036381.

  11. Saltzman AF, Carrasco A, Amini A, Cost NG.Patterns of Care and Survival Comparisonof Adult and Pediatric Wilms Tumor in theUnited States: A Study of the National CancerDatabase. Urology. 2020;135: 50–56. https://doi.org/10.1016/j.urology.2019.10.007.

  12. Hermi A, Mrad Dali K, Hadj Alouane H,Chelly B, Ben Rejeb N, Nouira Y. Adult’s Wilmstumor: A case report. Urology Case Reports.2022;44: 102171. https://doi.org/10.1016/j.eucr.2022.102171.

  13. Modi S, Tiang KW, Inglis P, Collins S. AdultWilms’ Tumour: Case Report and Review ofLiterature. Journal of Kidney Cancer and VHL.2016;3(2): 1–7. https://doi.org/10.15586/jkcvhl.2016.52.

  14. Huang JL, Liao Y, An Y, Qiu MX. Spontaneousrupture of adult Wilms’ tumor: A case reportand review of the literature. Canadian UrologicalAssociation Journal = Journal De l’Association DesUrologues Du Canada. 2015;9(7–8): E531-534.https://doi.org/10.5489/cuaj.2539.

  15. Re GG, Hazen-Martin DJ, Sens DA, GarvinAJ. Nephroblastoma (Wilms’ tumor): a modelsystem of aberrant renal development. Seminarsin Diagnostic Pathology. 1994;11(2): 126–135.

  16. Riccardi VM, Sujansky E, Smith AC, Francke U.Chromosomal imbalance in the Aniridia-Wilms’tumor association: 11p interstitial deletion.Pediatrics. 1978;61(4): 604–610.

  17. Martin-Dorantes M A, Rochel-Pérez E A,Chi-Méndez C G, Bastarrachea-Solis M A,Flores-Tapia J P, Méndez-Domínguez N. ‘No heescuchado que ´nadien´ conocido haya muertopor eso’: Percepciones sobre la prevención delcáncer de próstata en un grupo de hombresde Yucatán. Revista Mexicana de Urología.2024;84(5): 1–14.

  18. Gratias EJ, Dome JS, Jennings LJ, Chi YY, TianJ, Anderson J, et al. Association of Chromosome1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From theChildren’s Oncology Group. Journal of ClinicalOncology: Official Journal of the American Societyof Clinical Oncology. 2016;34(26): 3189–3194.https://doi.org/10.1200/JCO.2015.66.1140.

  19. Lopes RI, Lorenzo A. Recent advances in themanagement of Wilms’ tumor. F1000Research.

  20. 2017;6: 670. https://doi.org/10.12688/f1000research.10760.1.20. Dénes FT, Duarte RJ, Cristófani LM, Lopes RI.Pediatric Genitourinary Oncology. Frontiers inPediatrics. 2013;1: 48. https://doi.org/10.3389/fped.2013.00048.

  21. Kieran K, Ehrlich PF. Current surgical standardsof care in Wilms tumor. Urologic Oncology.2016;34(1): 13–23. https://doi.org/10.1016/j.urolonc.2015.05.029.

  22. Brok J, Treger TD, Gooskens SL, van denHeuvel-Eibrink MM, Pritchard-Jones K.Biology and treatment of renal tumours inchildhood. European Journal of Cancer (Oxford,England: 1990). 2016;68: 179–195. https://doi.org/10.1016/j.ejca.2016.09.005.

  23. Dome JS, Graf N, Geller JI, Fernandez CV,Mullen EA, Spreafico F, et al. Advances in WilmsTumor Treatment and Biology: Progress ThroughInternational Collaboration. Journal of ClinicalOncology: Official Journal of the American Societyof Clinical Oncology. 2015;33(27): 2999–3007.https://doi.org/10.1200/JCO.2015.62.1888.




2020     |     www.medigraphic.com